All lobbying filings

HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Lobbying for HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $30,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 5

S 998
Medical Supply Chain Resiliency Act
HR 2213
Medical Supply Chain Resiliency Act
S 891
Bipartisan Health Care Act
S 257
Promoting Resilient Supply Chains Act of 2025
HR 6140
Congressional Budget Office Scheduling Reform Act

Lobbying activity 3

Health Issues

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.

Transportation

S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act.

Tariff (miscellaneous tariff bills)

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.